Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Basaran Mutlu Agardan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmaceutical Development and Technology|November 13, 2020
<i>In vitro</i> and <i>in vivo</i> evaluations on nanoparticle and phospholipid hybrid nanoparticles with absorption enhancers for oral insulin deliveryN Basaran Mutlu-Agardan, S Han
Chemical Communications (Cambridge, England)|June 6, 2018
Redox-triggered intracellular siRNA deliveryN Basaran Mutlu Agardan, Can Sarisozen, Vladimir P Torchilin
Drug Development and Industrial Pharmacy|December 27, 2024
Development of immediate release tablet formulations of lornoxicam with hot melt extrusion-based three-dimensional printing technologyAysel Yilmaz, N Basaran Mutlu-Agardan, Sevgi Takka
Pharmaceutical Research|March 14, 2020
Cytotoxicity of Novel Redox Sensitive PEG<sub>2000</sub>-S-S-PTX Micelles against Drug-Resistant Ovarian and Breast Cancer CellsN Basaran Mutlu-Agardan, Can Sarisozen, Vladimir P Torchilin
Journal of Liposome Research|April 16, 2020
Development of effective AmB/AmB-αCD complex double loaded liposomes using a factorial design for systemic fungal infection treatmentN Basaran Mutlu-Agardan, Sukran Yilmaz, Fatma Kaynak Onurdag, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmaceutical Development and Technology|November 13, 2020
<i>In vitro</i> and <i>in vivo</i> evaluations on nanoparticle and phospholipid hybrid nanoparticles with absorption enhancers for oral insulin deliveryN Basaran Mutlu-Agardan, S Han
Chemical Communications (Cambridge, England)|June 6, 2018
Redox-triggered intracellular siRNA deliveryN Basaran Mutlu Agardan, Can Sarisozen, Vladimir P Torchilin
Drug Development and Industrial Pharmacy|December 27, 2024
Development of immediate release tablet formulations of lornoxicam with hot melt extrusion-based three-dimensional printing technologyAysel Yilmaz, N Basaran Mutlu-Agardan, Sevgi Takka
Pharmaceutical Research|March 14, 2020
Cytotoxicity of Novel Redox Sensitive PEG<sub>2000</sub>-S-S-PTX Micelles against Drug-Resistant Ovarian and Breast Cancer CellsN Basaran Mutlu-Agardan, Can Sarisozen, Vladimir P Torchilin
Journal of Liposome Research|April 16, 2020
Development of effective AmB/AmB-αCD complex double loaded liposomes using a factorial design for systemic fungal infection treatmentN Basaran Mutlu-Agardan, Sukran Yilmaz, Fatma Kaynak Onurdag, et al.
Pageof 1